EGFR tyrosine kinase inhibitors in non-small cell lung cancer (NSCLC) with EGFR activating mutations – real world data. (June 2021) - Dulloo, Sean; Almusarhed, Manar; Chen, Ryan; Akala, Oyeyemi; Varadhan, Balaji; Chauhan, Meera; Ahmed, Samreen